Centene Corporation CNC
61.82
(0.10)
(0.16%)
as of 25 Sep
- Market cap
- $30.6B
- P/E
- 0.0×
Follow CNC
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Centene Corporation (CNC) P/S ratio
As of 25 September 2026, Centene Corporation (CNC) trades at a P/S ratio of 0.2×. Over the past ten years it has ranged from 0.1× (August 2025) to 0.6× (August 2018); the current reading is higher than 8% of that period. That is below the Healthcare Plans industry median of 0.4× and below the Healthcare sector median of 3.8×.
P/S ratio, daily
Annual
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 0.1× | (46.23%) |
| FY2024 | 0.2× | (28.51%) |
| FY2023 | 0.3× | (14.56%) |
| FY2022 | 0.3× | (16.76%) |
| FY2021 | 0.4× | 23.65% |
| FY2020 | 0.3× | (11.48%) |
| FY2019 | 0.3× | (6.92%) |
| FY2018 | 0.4× | 2.32% |
| FY2017 | 0.4× | 59.55% |
| FY2016 | 0.2× | (33.45%) |
Quarterly
| Period | P/S ratio | Change |
|---|---|---|
| Jun 2026 | 0.2× | 92.13% |
| Mar 2026 | 0.1× | (21.98%) |
| Dec 2025 | 0.1× | 10.50% |
| Sep 2025 | 0.1× | (37.26%) |
| 42 more quarters | Free account |
Against its own ten years
Low 0.1×
High 0.6×
Ten-year median
0.3×
Current reading's percentile
8
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| CNC Centene Corporation | 0.2× |
| MOH Molina Healthcare, Inc compare | 0.2× |
| CI Cigna Group compare | 0.3× |
| CVS CVS Health Corporation compare | 0.3× |
| HUM Humana Inc. compare | 0.3× |
| ELV Elevance Health, Inc. compare | 0.4× |
| OSCR Oscar Health, Inc. compare | 0.6× |
| UNH UnitedHealth Group Incorporated compare | 0.8× |
| CLOV Clover Health Investments, Corp. compare | 1.0× |
| Healthcare Plans industry median | 0.4× |
| Healthcare sector median | 3.8× |
| Market median | 2.0× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on CNC
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement